Eş zamanlı Kronik Migren ve Temporomandibular Bozuklukları Bulunan Hastalarda OnabotulinumtoxinA Tedavisinin Değerlendirilmesi

Autor: Banu Gürkan Köseoğlu, Yeşim Gülşen, Başar Bilgiç, Gulsen Kocaman, Zeliha Matur, Betül Baykal, Mustafa Ertas, Neşe Kahraman
Přispěvatelé: MATUR, ZELİHA, İÜC, Diş Hekimliği Fakültesi, Klinik Bilimler Bölümü
Rok vydání: 2017
Předmět:
medicine.medical_specialty
Kocaman G.
Kahraman N.
Gurkan Koseoglu B.
Bilgic B.
Matur Z.
Ertas M.
Gulsen Y.
Baykan Baykal B.
-Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders-
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
cilt.55
ss.330-336
2018
business.industry
General Neuroscience
Medical record
Retrospective cohort study
Nörolojik Bilimler
medicine.disease
Comorbidity
Psikiyatri
stomatognathic diseases
Psychiatry and Mental health
Chronic Migraine
Migraine
Concomitant
Internal medicine
Physical therapy
Medicine
In patient
Erratum
Risk factor
business
human activities
Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders.-
Noro psikiyatri arsivi
cilt.56
sa.1
ss.83
2019 [Kocaman G.
Kahraman N.
Köseoğlu B. G.
Bilgiç B.
Matur Z.
Ertaş M.
Gülşen Y.
Baykan B.
-Erratum]
Research Article
Zdroj: Noro Psikiyatri Arsivi.
ISSN: 1309-4866
DOI: 10.5152/npa.2017.19257
Popis: Introduction: Migraine and temporomandibular disorders (TMD) are both common diseases and TMD are reported as a risk factor in migraine progression. OnabotulinumtoxinA is used in the treatment of chronic migraine (CM), and also has a potential role in TMD treatment. in this study, it is aimed to compare the efficacy of onabotulinumtoxinA treatment in CM patients with and without TMD. Methods: in this retrospective study, 30 CM patients (age range: 18–65 years), satisfying the inclusion and follow-up criteria in their medical records were investigated. the PREEMPT injection protocol was taken as reference and onabotulinumtoxinA 155–195 U with fixed-dose has been administered into 31 specific sites within the head/neck muscles in included subjects. Two cycles of treatment were assessed in all patients at the baseline and 12 weeks later. the headache diaries, which were completed routinely one month before, and during 6 months followup after the treatment, were assessed. the effect of onabotulinumtoxinA treatment was compared between CM patients with and without TMD/ bruxism. Results: of 30 female patients, 17 had concomitant TMD. in week 24, there were significant improvement in the groups with and without TMD regarding to the mean change of frequencies in the days with migraine compared to the initial findings (p
Databáze: OpenAIRE
Externí odkaz: